Drug and Therapeutics Bulletin 1999;37:36-40; doi:10.1136/dtb.1999.37536
Copyright © 1999 by the BMJ Publishing Group Ltd.
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation

Developments in the treatment of Parkinson's disease

Relevant BNF section: 4.9

Since we last reviewed the drug treatment of Parkinson's disease in 1995,1 several new drugs have been licensed for its treatment, more is known about the use of levodopa plus selegiline, and new surgical techniques have been developed. Here we review these new developments and consider how they affect patient management.






About DTB - Privacy policy - Terms and conditions relating to subscriptions purchased online - Web site terms and conditions - Feedback

© 1999 BMJ Publishing Group Ltd.